| After the Swiss parliament cut funding for a Basel to Malmö night train, Swissinfo journalist Kristian Brandt tried a similar route with his daughter. What followed was a day-long journey that shows the pluses, minuses and new opportunities for this alternative to flying. Visit Swissinfo to read more. --- swissinfo.ch is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to report on Switzerland and to provide a Swiss perspective on international events. For more articles, interviews and videos visit swissinfo.ch or subscribe to our YouTube channel. |
You Might Also Like
Could direct democracy trip up Swiss trade deals?
2026-03-19
As global trade rules fray, countries are scrambling to shore up export markets and diversify partners. For highly globalised, export-dependent Switzerland, there could be an added complication: the ballot box.
Visit Swissinfo to read more about this.
—
swissinfo.ch is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to report on Switzerland and to provide a Swiss perspective on international events.
For more articles, interviews and videos visit swissinfo.ch or subscribe to our YouTube channel.
Economists predict a weak economic year for Switzerland
2026-03-19
The Swiss government’s expert group expects economic growth of 1% – down from 1.1% forecast in December, according to the State Secretariat for Economic Affairs (SECO). This suggests the Swiss economy is likely to grow below average. The Swiss Economic Institute (KOF) at the federal technology institute ETH Zurich is also forecasting growth of 1%, …
Stranded in a crisis zone – who is responsible for repatriation?
2026-03-18
The military confrontation between Iran and a US–Israel-led alliance has entered its third week and impacted ten countries. Over 1,200 registered Swiss citizens remain in the Middle East region, yet no further repatriation flights are planned. Bern stresses personal responsibility, but criticism is mounting. Is it justified? The Gulf region – along with Israel – …
Bonus Episode – Inside Switzerland’s Quiet Rise as a Longevity Hub
2026-01-27
Send us a text (https://www.buzzsprout.com/twilio/text_messages/910414/open_sms)
How did longevity go from a social media trend to a focus of serious science?
In this special bonus episode our host, Jo Fahy, is joined in the studio by pharmaceuticals and healthcare reporter, Jessica Davis Pluss. We trace how Switzerland was uniquely positioned to become a global hub for healthier ageing. We also compare lifespan and health span, examine why access to clinics is so tightly guarded, and discuss why the pharmaceutical industry is moving cautiously in this growing field.
SWI swissinfo.ch (https://www.swissinfo.ch/eng/) is a public service media company based in Bern, Switzerland.
Swiss key interest rate expected to remain at zero percent
2025-12-08
The Swiss National Bank (SNB) is likely to continue its current zero interest rate policy on Thursday. Most economists do not expect the key interest rate to change in 2026 either. In a survey conducted by the news agency AWP, there is a broad consensus among the experts surveyed: the key interest rate is likely …
Swiss to relaunch auction for ‘SO 1’ number plate
2025-12-05
The Swiss online auction for the number plate “SO 1” will be reorganised. This is due to problematic bids that were received late on Thursday evening. +Get the most important news from Switzerland in your inbox The State Chancellery of canton Solothurn announced on Friday that serious offers of up to CHF357,000 ($444,000) had been …
World fights nicotine addiction but Switzerland continues to drag feet
2025-12-04
Geneva is home to the headquarters of the World Health Organization (WHO), yet Switzerland has not ratified the global convention on tobacco control and remains one of the countries where the tobacco industry has most influence. The 11th session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) …
Patent battle in India tests Roche’s grip on rare disease market
2025-10-16
An Indian court has cleared the way for low-cost alternatives to Roche’s drug Evrysdi for spinal muscular atrophy. What’s behind the decision and what could it mean for rare disease patients everywhere? On October 9 the Delhi High Court refused to issue Roche an injunction to prevent generic manufacturers from making and selling a low-cost …
Tags: Featured
1 pings